Farms.com Home   Ag Industry News

Syngulon and Elanco Partner for Advanced Animal Health Solutions

Syngulon and Elanco Partner for Advanced Animal Health Solutions
Mar 31, 2026
By Farms.com

Elanco licenses Syngulon bacteriocin technology to improve fermentation and animal health products

Syngulon SRL, a biotechnology company focused on genetic technologies for industrial fermentation, and Elanco Animal Health have announced a new partnership. Elanco has obtained a worldwide license to use Syngulon’s proprietary bacteriocin-based microbial selection technologies for developing and manufacturing animal health products. 

This technology helps improve microbial stability and efficiency in fermentation processes. It supports the production of important components like recombinant proteins and plasmid DNA, which are critical for many modern animal health solutions. By using this advanced approach, Elanco aims to enhance the quality and effectiveness of its products for farmers and livestock producers around the world. 

"We are pleased to collaborate with Elanco, a global leader in animal health, to enable broader application of our antibiotic-free fermentation technologies," said Guy Hélin, Chief Executive Officer of Syngulon. "This non-exclusive agreement validates the strength of our platform and supports our mission to provide innovative, sustainable solutions." 

"We are excited to work with Syngulon," said Mayur Patel, DVM, MVSc, MBA, Vice President, Global Research & Development at Elanco Animal Health. "Their bacteriocin-based technology represents an important advancement in microbial fermentation and supports our commitment to consistently deliver high-impact innovative solutions for animal health." 

Both companies emphasized that this partnership reflects their shared dedication to innovation, responsible biotechnology, and the development of next-generation animal health products. By combining Syngulon’s cutting-edge fermentation technology with Elanco’s global expertise, this collaboration aims to provide safer, more efficient, and sustainable solutions for the livestock industry. 

This agreement highlights the growing importance of biotechnology in animal health, focusing on sustainable practices, improved production methods, and the creation of high-quality products that benefit both producers and animals globally.

Photo Credit: gettyimages-seastock


Trending Video

Post-Weaning E. coli Control - Dr. Rodrigo Paiva

Video: Post-Weaning E. coli Control - Dr. Rodrigo Paiva


In this episode of The Swine it Podcast Show Canada, Dr. Rodrigo Paiva, DVM and PhD candidate at Iowa State University, explains how post weaning colibacillosis has changed in recent years and why pathogenic Escherichia coli has become more important in swine production. He discusses virulence factors, diagnosis, whole genome sequencing, biosecurity, and practical strategies to reduce disease risk while improving herd health. Listen now on all major platforms!

"Pathogenic E. coli now behaves like a robust, well-equipped truck carrying multiple tools for post-weaning disease."

Meet the guest: Dr. Rodrigo Paiva / rodrigo-paiva-09364355 is a veterinarian and PhD candidate at Iowa State University specializing in swine health, veterinary epidemiology, and post weaning colibacillosis. After several years working in commercial swine production in Brazil, his research has focused on understanding pathogenic Escherichia coli and improving disease prevention in modern production systems. Listen to Dr. Rodrigo Paiva on The Swine it Podcast Show Canada, available on all major platforms.